From: Anemia in severe heart failure patients: does it predict prognosis?
Variables | Â | Univariate analysis | Multivariate analysis | Â |
---|---|---|---|---|
 |  | Hazard ratio (95% CI) | Hazard ratio (95% CI) | P- value |
Gender | Female | 1.122 (0.643–1.958) | – |  |
Age, Years |  | 1.039 (1.021–1.058) | 1.041 (1.017–1.066) | 0.001* |
NYHA Class | Class IV | 1.622 (0.764–3.442) | 0.946 (0.402–2.227) | 0.899 |
Heart Rate, bpm |  | 1.005 (0.992–1.017) | – |  |
Systolic BP, mmHg |  | 1.017 (1.008–1.026) | 0.992 (0.975–1.009) | 0.367 |
Diastolic BP, mmHg |  | 1.031 (1.016–1.046) | 1.020 (0.997–1.044) | 0.089 |
Anemia |  | 1.740 (1.004–3.016) | 0.862 (0.439–1.693) | 0.666 |
Sodium, mEq/L |  | 0.937 (0.903–0.973) | 0.933 (0.882–0.987) | 0.016* |
Creatinine, mg/dl |  | 1.877 (1.636–2.155) | 1.869 (1.460–2.392) | <0.0001* |
AF | Yes | 0.535 (0.275–1.039) | 1.913 (0.583–6.272) | 0.284 |
VHD | Yes | 0.635 (0.366–1.103) | 0.821 (0.418–1.612) | 0.566 |
IHD | Yes | 2.261 (1.228–4.162) | 0.620 (0.256–1.501) | 0.289 |
HHD | Yes | 0.918 (0.449–1.876) | – |  |
DCMP | Yes | 0.878 (0.346–2.227) | – |  |
Cor pulmonare | Yes | 0.776 (0.106–5.691) | – |  |
Other etiology | Yes | 1.237 (0.443–3.453) | – |  |
LVEF, % |  | 0.977 (0.955–0.998) | 0.984 (0.955–1.014) | 0.283 |
Diuretics | Yes | 0.586 (0.229–1.496) | – |  |
Spironolactone | Yes | 0.359 (0.210–0.613) | 0.527 (0.276–0.996) | 0.050* |
ACEI | Yes | 0.546 (0.311–0.960) | 0.410 (0.197–0.852) | 0.017* |
Beta Blocker | Yes | 0.555 (0.320–0.964) | 0.578 (0.295–1.132) | 0.110 |
Digoxin | Yes | 0.401 (0.201–0.800) | 0.634 (0.225–1.791) | 0.390 |
Antiplatelates | Yes | 0.895 (0.478–1.674) | – |  |
Anticoagulants | Yes | 0.400 (0.180–0.888) | 0.841 (0.277–2.558) | 0.760 |
Statin | Yes | 1.431 (0.754–2.715) | – |  |
CCB | Yes | 1.524 (0744–3.119) | – |  |